Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NCM – Real Time Price. Currency in USD
8.74
+0.49 (5.94%)
At close: Jun 26, 2026, 4:00 PM EDT
8.60
-0.14 (-1.60%)
After-hours: Jun 26, 2026, 7:42 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
8.74
+0.49 (5.94%)
At close: Jun 26, 2026, 4:00 PM EDT
8.60
-0.14 (-1.60%)
After-hours: Jun 26, 2026, 7:42 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $26.0M significantly exceed its total debt $1.2M, ensuring strong financial flexibility
Total current assets $143.6M exceed Total current liabilities $18.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$25.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.92 | 6.05 | 10 | |
| Quick ratio | 7.92 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -641K | -600K | -233K | -298K |
| Operating Income | -35M | -45M | -49M | -85M | -90M |
| Net Income | -42M | -45M | -40M | -79M | -85M |
| EBITDA | -33M | -44M | -48M | -85M | -90M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 12.59 | 4.5 |
| Next quarter | N/A | 44.66 | 5.5 |
| Current year | N/A | 21.34 | 5.5 |
| Next year | 116 | -10.89 | 5.5 |
| Weighted average score | 5.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -11.73 | 1.6 | -60.57 | 3.8 |
| Y/Y | 999 | -35.28 | 11.51 | -55.75 | 4.8 |
| 3y average | 999 | -30.25 | 0.81 | -22.05 | 3.5 |
| 5y average | 563.88 | -4.91 | 16.98 | 1.56 | 5.8 |
| Weighted average score | 4.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |